These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 21718088)
1. The pharmacokinetics of recombinant human interferon-alpha-2b poly(lactic-co-glycolic acid) microspheres in rats. Yang F; Shu YJ; Yang YQ; Song FL; Pan YF; Long XY; Chen G; Zhang YM J Microencapsul; 2011; 28(6):483-9. PubMed ID: 21718088 [TBL] [Abstract][Full Text] [Related]
2. Recombinant interferon-alpha2b poly(lactic-co-glycolic acid) microspheres: pharmacokinetics-pharmacodynamics study in rhesus monkeys following intramuscular administration. Zhang YM; Yang F; Yang YQ; Song FL; Xu AL Acta Pharmacol Sin; 2008 Nov; 29(11):1370-5. PubMed ID: 18954532 [TBL] [Abstract][Full Text] [Related]
3. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres. Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486 [TBL] [Abstract][Full Text] [Related]
4. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method. Kang J; Wu F; Cai Y; Xu M; He M; Yuan W Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681 [TBL] [Abstract][Full Text] [Related]
5. Preparation of bleomycin A2-PLGA microspheres and related in vitro and in vivo studies. Zhang H; Gao Y; Lv W; Jiao C; Duan M; Liu H; Han B J Pharm Sci; 2011 Jul; 100(7):2790-800. PubMed ID: 21344412 [TBL] [Abstract][Full Text] [Related]
6. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique. Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816 [TBL] [Abstract][Full Text] [Related]
7. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles. Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348 [TBL] [Abstract][Full Text] [Related]
8. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity. Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic profiles of recombinant human erythropoietin-loaded poly(lactic-co-glycolic acid) microspheres in rats. Zhou XL; He JT; Du HJ; Fan YY; Wang Y; Zhang HX; Jiang Y Acta Pharmacol Sin; 2012 Jan; 33(1):137-44. PubMed ID: 22139004 [TBL] [Abstract][Full Text] [Related]
10. Development of interferon alpha-2b microspheres with constant release. Li Z; Li L; Liu Y; Zhang H; Li X; Luo F; Mei X Int J Pharm; 2011 May; 410(1-2):48-53. PubMed ID: 21419205 [TBL] [Abstract][Full Text] [Related]
11. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. He J; Feng M; Zhou X; Ma S; Jiang Y; Wang Y; Zhang H Int J Pharm; 2011 Sep; 416(1):69-76. PubMed ID: 21699969 [TBL] [Abstract][Full Text] [Related]
12. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles. Feczkó T; Fodor-Kardos A; Sivakumaran M; Haque Shubhra QT Nanomedicine (Lond); 2016 Aug; 11(16):2029-34. PubMed ID: 27462975 [TBL] [Abstract][Full Text] [Related]
13. [Preparation of sustained release microspheres containing oxymatrine and their release characteristics in vitro]. Miao Y; Shen XC; Xiao CD; Wu LF; Zhou X; Tao L Zhong Yao Cai; 2012 Oct; 35(10):1674-9. PubMed ID: 23627137 [TBL] [Abstract][Full Text] [Related]
14. Effects of releasing recombinant human growth and differentiation factor-5 from poly(lactic-co-glycolic acid) microspheres for repair of the rat degenerated intervertebral disc. Yan J; Yang S; Sun H; Guo D; Wu B; Ji F; Zhou D J Biomater Appl; 2014 Jul; 29(1):72-80. PubMed ID: 24327349 [TBL] [Abstract][Full Text] [Related]
15. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis. Ohashi K; Kabasawa T; Ozeki T; Okada H J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349 [TBL] [Abstract][Full Text] [Related]
16. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B. Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638 [TBL] [Abstract][Full Text] [Related]
17. Microsphere delivery of Risperidone as an alternative to combination therapy. D'Souza S; Faraj J; DeLuca P Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159 [TBL] [Abstract][Full Text] [Related]
18. Sustained-release delivery of octreotide from biodegradable polymeric microspheres. Rhee YS; Sohn M; Woo BH; Thanoo BC; DeLuca PP; Mansour HM AAPS PharmSciTech; 2011 Dec; 12(4):1293-301. PubMed ID: 21948321 [TBL] [Abstract][Full Text] [Related]
19. Nanostructured microspheres produced by supercritical fluid extraction of emulsions. Della Porta G; Reverchon E Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Chu DF; Fu XQ; Liu WH; Liu K; Li YX Int J Pharm; 2006 Nov; 325(1-2):116-23. PubMed ID: 16876971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]